Experience

Biocept, Inc.

• United States
• Biotechnology Research
• 1 - 100 Employee

• Director of Managed Care (Payer Relations, Health Economics & Outcomes Research)

  • Dec 2021 - Present

  San Diego Metropolitan Area



Skysis LLC, a Fishawack Health Company

• Principal: Health Economics and Outcomes Research, Real World Data, Real World Evidence

  • Apr 2021 - Dec 2021

  Boston, Massachusetts, United States



Voisin Consulting Life Sciences (VCLS)

• France
• Biotechnology Research
• 100 - 200 Employee

• U.S. Engagement Manager: Health Economics and Outcomes Research, Real World Evidence, Market Access

  • May 2019 - Apr 2021

  Greater Boston Area Voisin Consulting Life Sciences supports life sciences companies throughout product development, the regulatory process and commercialization of new and existing product portfolios. Our core focus at VCLS is the integration of value-based evidence requirements into clinical development programs. We provide strategic recommendations for positioning product value to ensure optimal patient access and reimbursement. We also advise on HTA requirements and design of appropriate clinical trials to… Show more Voisin Consulting Life Sciences supports life sciences companies throughout product development, the regulatory process and commercialization of new and existing product portfolios. Our core focus at VCLS is the integration of value-based evidence requirements into clinical development programs. We provide strategic recommendations for positioning product value to ensure optimal patient access and reimbursement. We also advise on HTA requirements and design of appropriate clinical trials to support efficient market access strategies. Show less



American College of Healthcare Executives

• United States
• Non-profit Organizations
• 100 - 200 Employee

• Member

  • 2007 - Apr 2021

  ACHE is a professional society dedicated to the highest standards of executive performance; the promulgation of continuing education for improved administration; the betterment of patient care through the efficient management of hospitals and related health organizations and services.



McCann Health New York

• Managing Director, Consulting at McCann Health

  • Mar 2017 - Jun 2019

  Greater New York City Area Managing Director, HEOR, Health Policy, Evidence.



Vyant Bio

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Director, Reimbursement, Revenue Cycle Management

  • Jan 2015 - Mar 2017

  NJ/ NY Oncology focused diagnostic testing (DNA-based tests) organization.



Healthcare Management Solutions, LLC

• National Director, HEOR, Reimbursement, Market Access Strategy

  • Mar 2013 - Jan 2015

  National Responsible for the design and development of HTA health economic, reimbursement, health policy, market access platform strategy on behalf of a number of medical device, pharmaceutical, life sciences organizations.



Scientia Advisors

• United States
• Business Consulting and Services
• 1 - 100 Employee

• Manager, HEOR, Reimbursement, Real World Evidence, Global Reimbursement Market Access Practice

  • Jun 2011 - 2013

  Cambridge, MA Scientia Advisors is a global management consulting firm specializing in growth strategies for major and emerging companies in healthcare and life sciences. Responsible for developing health economic,reimbursement, and health policy strategies for client organizations (medical device, pharmaceutical, diagnostic, life sciences)



Well Doc, Inc.

• Director of Reimbursement Strategy and Managed Markets

  • May 2011 - Nov 2012

  Baltimore, Maryland Area Responsible for the development and management of all managed care payer relations, reimbursement strategy and implementation, health economic platform development, healthcare policy. Type 2 Diabetes Self-Management Clinical Platform



ImpediMed

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• National Director of Health Economics, Reimbursement, Market Access Development

  • Jun 2008 - Oct 2011

  San Diego, CA Responsible for the development and management of the company's overall managed care payer strategy, economic/ reimbursement platform policy development, health economics value dossier development, real world evidence development, government policy, market access platform development.